BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25519846)

  • 21. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
    Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
    Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pycnogenol® in postpartum symptomatic hemorrhoids.
    Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
    Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
    Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pycnogenol® improvements in asthma management.
    Belcaro G; Luzzi R; Cesinaro Di Rocco P; Cesarone MR; Dugall M; Feragalli B; Errichi BM; Ippolito E; Grossi MG; Hosoi M; Errichi S; Cornelli U; Ledda A; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):57-64. PubMed ID: 22108478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
    Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
    Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
    Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
    Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
    Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
    Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Nargi E; Patricelli P; Bucci M
    Angiology; 2001 Oct; 52 Suppl 2():S27-31. PubMed ID: 11666119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
    Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
    Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flight microangiopathy in medium- to long-distance flights: prevention of edema and microcirculation alterations with total triterpenic fraction of Centella asiatica.
    Cesarone MR; Incandela L; De Sanctis MT; Belcaro G; Geroulakos G; Griffin M; Lennox A; Di Renzo AD; Cacchio M; Bucci M
    Angiology; 2001 Oct; 52 Suppl 2():S33-7. PubMed ID: 11666121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk.
    Saumoy M; Alonso-Villaverde C; Navarro A; Olmo M; Vila R; Ramon JM; Di Yacovo S; Ferrer E; Curto J; Vernet A; Vila A; Podzamczer D
    Atherosclerosis; 2016 Mar; 246():301-8. PubMed ID: 26826629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pycnogenol®-Centellicum® supplementation improves lung fibrosis and post-COVID-19 lung healing.
    Cesarone MR; Hu S; Belcaro G; Cornelli U; Feragalli B; Corsi M; Bombardelli E; Cotellese R; Hosoi M; Rosenkvist L
    Minerva Med; 2022 Feb; 113(1):135-140. PubMed ID: 34180638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy.
    Belcaro G; Cotellese R; Corsi M; Cesarone MR; Scipione C; Scipione V; Cornelli U; Ippolito E; Dugall M; Hosoi M; Feragalli B
    Minerva Surg; 2024 Jun; 79(3):309-314. PubMed ID: 38847768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B; Henriksson M; Lundin F; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical peripheral arterial disease in rheumatoid arthritis.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Kyrkou K; Zampeli E; Fragiadaki K; Panoulas VF; Mavrikakis M; Sfikakis PP
    Atherosclerosis; 2010 Sep; 212(1):305-9. PubMed ID: 20553683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carotid endarterectomy for asymptomatic carotid stenosis in the very elderly.
    Ballotta E; Toniato A; Da Roit A; Lorenzetti R; Piatto G; Baracchini C
    J Vasc Surg; 2015 Feb; 61(2):382-8. PubMed ID: 25175628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).
    Belcaro G; Nicolaides AN; Ramaswami G; Cesarone MR; De Sanctis M; Incandela L; Ferrari P; Geroulakos G; Barsotti A; Griffin M; Dhanjil S; Sabetai M; Bucci M; Martines G
    Atherosclerosis; 2001 Jun; 156(2):379-87. PubMed ID: 11395035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.